CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 51 enrolled
Drug / intervention
Skin sample +4 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01040104
NCT01040104N/ACompleted

Pilot Study of Prospective Clinical Trials on Skin Wound Healing in Young and Aged Individuals

Medical University of Vienna·observational·Posted Dec 29, 2009·Updated Nov 13, 2013

In Brief

An observational study evaluating Skin sample, Skin biopsy, and 1 other intervention for Age and 3 related conditions. Completed, enrolled 51 participants across 1 site.

Detailed Summary

Regular wound healing follows a well-ordered sequence of overlapping phases: inflammation, proliferation, maturation and remodelling. In the young, damage to an organ mostly triggers fully regenerative mechanisms called "primary" wound healing. Repeated damage in young individuals may cause "secondary" wound healing eg. scar formation reflecting a rescue program, in which reorganisation has failed. Organ failure in the ageing organism is characterized by a progressive loss of its capability to achieve an orderly reactivation of organ repair, and results in a combination of chronic inflammation and fibroproliferative, non-regenerative repair affecting several organs, including lung, liver and skin. RESOLVE's objective is to identify, characterize, and validate molecular targets responsible for shifting primary organ repair towards fibroproliferative wound healing as a result of an age-dependent loss of regulatory control. The structured approach is based on * different forms of wound healing, * different human diseases and * different genetic backgrounds, aiming to provide future diagnostic tools in various organs, to create transgenic animal test systems, and to identify molecular targets involved in fibroproliferative wound healing.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesAustria
CollaboratorsEuropean Union

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 29, 2009
Enrollment StartJul 1, 2009
Primary CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 16.5 years ago

Interventions

Skin sampleother

Taken from regularly discarded tissue during routine operation

Skin biopsyother

Skin biopsy from regions exhibiting normal and/or hypertrophic scarring at day 0 and day 90

Skin biopsyother

Biopsy from skin graft harvest site during routine operation on day 0 and follow-up on day 90

Blood takingother

Blood taking on day 0

Blood takingother

Blood taking on day 90